About the Event
bit.bio is unlocking the therapeutic potential of human cells with cell reprogramming. Their proprietary technology can create any desired cell type in days, not months, and at a quality required to create novel cell therapies.
Join our webinar with bit.bio co-founder and Chief Corporate Officer, Florian Schuster, to learn how their platform technology will transform medicine by making cell therapies accessible to millions of patients.